3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Status
Completed
2
Withdrawn
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Conditions
Neoplasms
9
Pain
8
Pain, Postoperative
5
Breast Neoplasms
5
Depression
4
Agnosia
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pain, Intractable
2
Chronic Pain
2
Acute Pain
2
Prostatic Neoplasms
1
Postoperative Analgesia
1
Peripheral Nervous System Diseases
1
Pelvic Neoplasms
1
Pancreatic Neoplasms
1
Neurotoxicity Syndromes
1
Neuralgia
1
Mucositis
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Hypoxia
1
Head and Neck Neoplasms
1
Emergence Delirium
1
Depressive Disorder, Major
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Choledocholithiasis
1
Choledochal Cyst
1
Cholangitis
1
Cancer Pain
1
Interventions
Ketamine
2
substance P-saporin
1
Infusion Pumps, Implantable
1
Fentanyl
1
Dexmedetomidine
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Pain, Intractable
×
Ketamine
×
Clear all
NCT01326325
2013-08-07
KEPAL
Assistance Publique - Hôpitaux de Paris
Phase 3
Completed
24 enrolled
NCT00484484
2011-05-04
KETADOL
Assistance Publique - Hôpitaux de Paris
Phase 3
Completed
100 enrolled